Prime Minister Narendra Modi stated that India’s pharmaceutical sector is evolving from being the world’s pharmacy to a center of innovation. Emphasizing the nation’s shift towards research-driven progress, PM Modi highlighted India’s transformation from a global provider of affordable medicines to a hub of pharmaceutical innovation.
In a post on X, PM Modi shared an article authored by Union Health Minister Jagat Prakash Nadda, underscoring India’s advancement up the value chain in the pharma sector. The focus has been on research and development, biologics, biosimilars, and cutting-edge therapies under the current government.
PM Modi described India’s pharma sector’s journey as moving towards innovation, with a strong emphasis on R&D, biologics, biosimilars, and advanced therapies. The Prime Minister highlighted the article by Nadda as essential reading, showcasing how India is gearing up to lead the global pharmaceutical industry.
The article highlighted the significant role of policy support and government focus in reshaping India’s pharmaceutical sector. It pointed out the country’s shift from mass production of generic drugs to investing in advanced research and complex drug development.
India’s focus on innovation-driven growth, including R&D investments and support for cutting-edge therapies, has been a key priority under the government. The sector’s increasing emphasis on biologics and biosimilars is expected to propel growth in the global pharmaceutical industry’s upcoming phase.
Union Minister Nadda, in the article, noted India’s transition from being known as the ‘Pharmacy of the World’ for generic medicines to gearing up for innovation.
